Correspondence 0001193125-23-003577 from BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: Jan. 6, 2023 · CIK: 0000811240 · Accession: 0001193125-23-003577
AI Filing Summary & Sentiment
File numbers found in text: 333-268528
Letter
January 6, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Jessica Ansart
Re:
BIOLASE, Inc.
Registration Statement on Form S-1
File No. 333-268528
Withdrawal of Acceleration Request
Resubmission of Acceleration Request
Ladies and Gentlemen:
Please refer to the acceleration request (the “Prior Acceleration Request”) submitted on January 4, 2023 (requesting effectiveness on January 5, 2023) by BIOLASE, Inc. (the “Registrant”), pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, with respect to the Registrant’s registration statement on Form S-1 (Registration Number 333-268528 (as amended, the “Registration Statement”).
Withdrawal of Acceleration Request
The Registrant hereby formally withdraws the Prior Acceleration Request.
Resubmission of Acceleration Request
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Registrant hereby requests that the effective date of the Registration Statement be accelerated so that the Registration Statement will become effective at 5:00 P.M. Eastern Time, on January 9, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
If you have any questions or require any additional information with respect to any of the matters discussed in this letter, please contact Istvan Hajdu of Sidley Austin LLP, counsel to the Registrant, at (212) 839-5651.
Very truly yours,
By:
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 6, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Jessica Ansart Re: BIOLASE, Inc. Registration Statement on Form S-1 File No. 333-268528 Withdrawal of Acceleration Request Resubmission of Acceleration Request Ladies and Gentlemen: Please refer to the acceleration request (the “Prior Acceleration Request”) submitted on January 4, 2023 (requesting effectiveness on January 5, 2023) by BIOLASE, Inc. (the “Registrant”), pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, with respect to the Registrant’s registration statement on Form S-1 (Registration Number 333-268528 (as amended, the “Registration Statement”). Withdrawal of Acceleration Request The Registrant hereby formally withdraws the Prior Acceleration Request. Resubmission of Acceleration Request Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Registrant hereby requests that the effective date of the Registration Statement be accelerated so that the Registration Statement will become effective at 5:00 P.M. Eastern Time, on January 9, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. If you have any questions or require any additional information with respect to any of the matters discussed in this letter, please contact Istvan Hajdu of Sidley Austin LLP, counsel to the Registrant, at (212) 839-5651. Very truly yours, By: /s/ Michael Carroll Michael Carroll Secretary BIOLASE, Inc. cc: John R. Beaver, Chief Executive Officer Jennifer Bright, Chief Financial Officer Michael Carroll, Secretary Beth Berg, Sidley Austin LLP Istvan A. Hajdu, Sidley Austin LLP David E. Danovitch, Sullivan & Worcester LLP Aaron M. Schleicher, Sullivan & Worcester LLP